TY - JOUR T1 - Forecasting the Spread of COVID-19 under Different Reopening Strategies JF - medRxiv DO - 10.1101/2020.05.26.20113993 SP - 2020.05.26.20113993 AU - Meng Liu AU - Raphael Thomadsen AU - Song Yao Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/30/2020.05.26.20113993.abstract N2 - We combine COVID-19 case data with mobility data to estimate a modified susceptible-infected-recovered (SIR) model in the United States. In contrast to a standard SIR model, we find that the incidence of COVID-19 spread is concave in the number of infectious individuals, as would be expected if people have inter-related social networks. This concave shape has a significant impact on forecasted COVID-19 cases. In particular, our model forecasts that the number of COVID-19 cases would only have an exponential growth for a brief period at the beginning of the contagion event or right after a reopening, but would quickly settle into a prolonged period of time with stable, slightly declining levels of disease spread. This pattern is consistent with observed levels of COVID-19 cases in the US, but inconsistent with standard SIR modeling. We forecast rates of new cases for COVID-19 under different social distancing norms and find that if social distancing is eliminated there will be a massive increase in the cases of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://github.com/songyao21/covid_data_depot Funding StatementNo external funding received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Only publicly available (or corporate-owned but available to all academic researchers) data was used.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesMost of the data we use is publicly available from multiple sources, and we lay out our sources ad where researchers can access this data clearly. Cell phone stay-at-home rates are from SafeGraph, which is available for free from all researchers studying COVID-19. We cannot share this data, but it is widely available, so the paper is auditable. https://github.com/songyao21/covid_data_depot ER -